Adult congenital heart disease

Robert Seal1

  • 1Department of Anesthesia and Pain Medicine, University of Alberta and Stollery Children's Hospital, Edmonton, AB, Canada. rseal@ualberta.ca

Paediatric Anaesthesia
|April 13, 2011
PubMed

Insights

Optimal anesthetic management for adults with congenital heart disease (CHD) requires a skilled multidisciplinary team. This approach is crucial as the CHD population grows and presents complex cases needing specialized care.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Adult Congenital Heart Disease (ACHD)

Background:

  • The population of adults with congenital heart disease (CHD) is increasing in size and complexity.
  • Optimal management of ACHD necessitates a skilled multidisciplinary team approach.
  • Anesthetic considerations for this growing population require specialized knowledge.

Purpose of the Study:

  • To review general anesthetic considerations for adults with CHD undergoing cardiac and noncardiac surgery.
  • To elaborate on anesthetic management for complex ACHD patient types.
  • To discuss the advantages of a multidisciplinary approach in ACHD care.

Main Methods:

  • Literature review of anesthetic management in adult congenital heart disease.
  • Synthesis of general and specialized anesthetic considerations.
  • Discussion of multidisciplinary team benefits.

Main Results:

  • Anesthetic management for ACHD patients requires careful consideration of their unique cardiac conditions.
  • Specific anesthetic strategies are necessary for various complex ACHD patient profiles.
  • Multidisciplinary collaboration enhances patient outcomes and care quality.

Conclusions:

  • A skilled multidisciplinary team is essential for optimal ACHD management.
  • Anesthesiologists must be aware of the complexities of CHD when providing perioperative care.
  • Organized, team-based care improves outcomes for adults with congenital heart disease.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...